ArticleOpen life sciences2025

GFPT2 promotes paclitaxel resistance in epithelial ovarian cancer cells via activating NF-κB signaling pathway.

Zi-Jun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.